Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q2 2020
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Jun 30, 2020
Net Income	-48.07M	-55.49M	-40.62M	-10.33M	-7.56M	10.55M
Depreciation & Amortization	39K	32K	25K	18K	n/a	n/a
Stock-Based Compensation	1.55M	1.1M	668K	560K	n/a	n/a
Other Working Capital	36.06M	35.86M	36.42M	35.56M	676.16K	n/a
Other Non-Cash Items	-49.05M	-31.83M	-31.83M	-54.84M	6.67M	-10.55M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	17.15M	25.13M	27.96M	30.14M	710.98K	n/a
Operating Cash Flow	-78.37M	-61.05M	-43.79M	-23.9M	10.37M	10.55M
Capital Expenditures	-35K	-35K	-25K	-20K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-35K	-35K	-25K	-20K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-7.74M	-7.74M	-7.74M	n/a	n/a	n/a
Other Financial Acitivies	68.97M	66.94M	70.73M	49.19M	n/a	n/a
Financial Cash Flow	61.23M	59.21M	62.99M	49.19M	n/a	n/a
Net Cash Flow	-636.2M	-646.42M	-629.14M	-623.05M	10.37M	10.55M
Free Cash Flow	-78.41M	-61.09M	-43.81M	-23.92M	10.37M	10.55M